Interleukin-1 receptors in the brain: characterization by quantitative in situ autoradiography.
Autoradiography was performed on mouse brain cryosections to localize interleukin-1 (IL-1) receptors in the mouse brain and pituitary gland and to identify the cell types expressing these receptors. Interleukin-1 receptor binding sites were mapped in the mouse central nervous system (CNS) with [125I]IL-1 alpha and [125I]IL-1 beta. IL-1 receptors were detected in high density in the dentate gyrus of the hippocampus, choroid plexus, meninges, and anterior pituitary. IL-1 receptors are also expressed in the frontoparietal cortex at very low density. Both neurons and glial cells were shown to express IL-1 receptors. An intrahippocampal injection of colchicine, a selective neurotoxin, induced the concurrent disappearance of neuronal cells and [125I]IL-1 alpha binding in the hippocampus. This treatment established that IL-1 bound to the neurons of the dentate gyrus. IL-1 receptors on glial cells were not detected in situ in the CNS under basal conditions. However, [125I]IL-1 alpha bound to glial cells at the site of astrogliosis induced by a local mechanical injury. These results suggest that activated astrocytes express IL-1 receptors. Furthermore, the results of histoautoradiography of [125I]IL-1 alpha binding on astrocyte and microglial cultures showed that astrocytes express IL-1 receptors in vitro. The biochemical characterization of IL-1 binding in the dentate gyrus was achieved by quantitative in situ autoradiography. In the dentate gyrus IL-1 bound to a single class of receptor with characteristics similar to those of the receptor expressed on immune cells (Kd = 0.3 +/- 0.2 nM, Bmax = 60 +/- 10 fmol/mg protein). Competition experiments with IL-1 alpha and IL-1 beta showed that the neuronal receptor characteristics were similar to those of the type I IL-1 receptor, which binds the two isoforms of IL-1 with the same affinity. Regulation of IL-1 receptor density in the CNS and pituitary was studied after peripheral injection of LPS. Stimulation of IL-1 synthesis by LPS was shown to induce a major decrease in the number of receptors available for IL-1 binding in the CNS. A decrease of 84 +/- 9% was observed in the dentate gyrus and in the choroid plexus, but no change occurred in the pituitary gland.
Ban
E M
EM
Department of Physiology and Biophysics, University of Alabama at Birmingham 35294-0005.
D000818:Animals; D001345:Autoradiography / Q000379:methods*; D001921:Brain / Q000166:cytology*; D001923:Brain Chemistry; D003078:Colchicine / Q000633:toxicity; D003720:Densitometry / Q000379:methods*; D005260:Female; D006624:Hippocampus / Q000737:chemistry / Q000166:cytology / Q000187:drug effects; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000633:toxicity; D051379:Mice; D008809:Mice, Inbred C3H; D008970:Molecular Weight; D009457:Neuroglia / Q000737:chemistry; D009474:Neurons / Q000737:chemistry; D010902:Pituitary Gland / Q000737:chemistry* / Q000166:cytology; D017472:Receptors, Interleukin-1 / Q000032:analysis* / Q000187:drug effects; D011994:Recombinant Proteins / Q000378:metabolism; D013047:Specific Pathogen-Free Organisms
D007375:Interleukin-1; D008070:Lipopolysaccharides; D017472:Receptors, Interleukin-1; D011994:Recombinant Proteins; D003078:Colchicine